{
   "rows":[
     {
        "Company": "Company 1",
        "Drug": "bb2121",
        "Origin": "U.S.",
        "Phase": "2",
        "Goal": "150",
        "Enrollment": "100",
        "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
        "TrialLastUpdated": "9/11/19",
        "StartDate": "12/13/17",
        "PrimaryCompletionDate": "11/1/24",
        "StudyCompletionDate": "11/1/24",
        "Target": "BCMA",
        "BreakthroughDesignation": "Y",
        "Date": "2015"
     },
     {
        "Company": "Company 2",
        "Drug": "bb2121",
        "Origin": "U.S.",
        "Phase": "2",
        "Goal": "150",
        "Enrollment": "100",
        "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
        "TrialLastUpdated": "9/11/19",
        "StartDate": "12/13/17",
        "PrimaryCompletionDate": "11/1/24",
        "StudyCompletionDate": "11/1/24",
        "Target": "BCMA",
        "BreakthroughDesignation": "Y",
        "Date": "2016"
     },
     {
        "Company": "Company 3",
        "Drug": "bb2121",
        "Origin": "U.S.",
        "Phase": "2",
        "Goal": "150",
        "Enrollment": "100",
        "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
        "TrialLastUpdated": "9/11/19",
        "StartDate": "12/13/17",
        "PrimaryCompletionDate": "11/1/24",
        "StudyCompletionDate": "11/1/24",
        "Target": "BCMA",
        "BreakthroughDesignation": "Y",
        "Date": "2017"
     },
     {
         "Company": "Company 4",
         "Drug": "bb2121",
         "Origin": "U.S.",
         "Phase": "2",
         "Goal": "150",
         "Enrollment": "100",
         "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
         "TrialLastUpdated": "9/11/19",
         "StartDate": "12/13/17",
         "PrimaryCompletionDate": "11/1/24",
         "StudyCompletionDate": "11/1/24",
         "Target": "BCMA",
         "BreakthroughDesignation": "Y",
         "Date": "2018"
      },
      {
         "Company": "Company 5",
         "Drug": "bb2121",
         "Origin": "U.S.",
         "Phase": "3",
         "Goal": "250",
         "Enrollment": "150",
         "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
         "TrialLastUpdated": "9/11/19",
         "StartDate": "12/13/17",
         "PrimaryCompletionDate": "11/1/24",
         "StudyCompletionDate": "11/1/24",
         "Target": "BCMA",
         "BreakthroughDesignation": "Y",
         "Date": "2019"
      },
      {
         "Company": "Company 6",
         "Drug": "bb2121",
         "Origin": "U.S.",
         "Phase": "2",
         "Goal": "150",
         "Enrollment": "100",
         "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
         "TrialLastUpdated": "9/11/19",
         "StartDate": "12/13/17",
         "PrimaryCompletionDate": "11/1/24",
         "StudyCompletionDate": "11/1/24",
         "Target": "BCMA",
         "BreakthroughDesignation": "Y",
         "Date": "2020"
      },
      {
         "Company": "Company 7",
         "Drug": "bb2121",
         "Origin": "U.S.",
         "Phase": "2",
         "Goal": "150",
         "Enrollment": "100",
         "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
         "TrialLastUpdated": "9/11/19",
         "StartDate": "12/13/17",
         "PrimaryCompletionDate": "11/1/24",
         "StudyCompletionDate": "11/1/24",
         "Target": "BCMA",
         "BreakthroughDesignation": "Y",
         "Date": "2021"
      },
      {
         "Company": "Company 8",
         "Drug": "bb2121",
         "Origin": "U.S.",
         "Phase": "2",
         "Goal": "150",
         "Enrollment": "100",
         "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
         "TrialLastUpdated": "9/11/19",
         "StartDate": "12/13/17",
         "PrimaryCompletionDate": "11/1/24",
         "StudyCompletionDate": "11/1/24",
         "Target": "BCMA",
         "BreakthroughDesignation": "Y",
         "Date": "2022"
      },
      {
          "Company": "Company 9",
          "Drug": "bb2121",
          "Origin": "U.S.",
          "Phase": "2",
          "Goal": "150",
          "Enrollment": "100",
          "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
          "TrialLastUpdated": "9/11/19",
          "StartDate": "12/13/17",
          "PrimaryCompletionDate": "11/1/24",
          "StudyCompletionDate": "11/1/24",
          "Target": "BCMA",
          "BreakthroughDesignation": "Y",
          "Date": "2023"
       },
       {
          "Company": "Company 10",
          "Drug": "bb2121",
          "Origin": "U.S.",
          "Phase": "3",
          "Goal": "250",
          "Enrollment": "150",
          "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
          "TrialLastUpdated": "9/11/19",
          "StartDate": "12/13/17",
          "PrimaryCompletionDate": "11/1/24",
          "StudyCompletionDate": "11/1/24",
          "Target": "BCMA",
          "BreakthroughDesignation": "Y",
          "Date": "2024"
       },
       {
          "Company": "Company 11",
          "Drug": "bb2121",
          "Origin": "U.S.",
          "Phase": "3",
          "Goal": "250",
          "Enrollment": "150",
          "Countries": "Belgium, Canada, France, Germany, Italy, Japan, Spain, United States",
          "TrialLastUpdated": "9/11/19",
          "StartDate": "12/13/17",
          "PrimaryCompletionDate": "11/1/24",
          "StudyCompletionDate": "11/1/24",
          "Target": "BCMA",
          "BreakthroughDesignation": "Y",
          "Date": "2025"
       }
   ]
}
